Who are the Drug Delivery CDMO Market Top Vendors and What are Their Offerings?
Company Overview
| Companies | Headquarters | Drug Delivery CDMO Services |
| Lonza Group AG | Basel, Switzerland | High-potency OSD, jet milling, and spray-dried dispersions |
| Catalent, Inc. | Somerset, U.S. | Softgel innovation, modified release technologies, and large-scale lipid-based delivery |
| Thermo Fisher Scientific | Waltham, U.S. | End-to-end oral solid dosage, next-gen on-body delivery systems, and sterile injectables |
| Samsung Biologics | Incheon, South Korea | Offers industrial-scale biologics |
| WuXi AppTec/WuXi Biologics | Shanghai, China | Integrated discovery-to-manufacturing services |
| Recipharm AB | Stockholm, Sweden | High-potency API manufacturing, smart device integration, and pulmonary delivery |
| Siegfried Holding AG | Zofingen, Switzerland | Offers ophthalmic and nasal delivery systems |
| Boehringer Ingelheim | Ingelheim am Rhein, Germany | Specialized high-volume fill finish services |
| Kindeva Drug Delivery | Woodbury, U.S. | Offers expertise for complex combination development |
| Piramal Pharma Solutions | Mumbai, India | High-potency API services, integrated sterile injectable manufacturing, and cancer drug delivery |
Market Growth
The drug delivery CDMO market is experiencing significant expansion, with projections indicating a revenue increase reaching several hundred million dollars by the end of the forecast period, spanning 2026 to 2035. This growth is driven by emerging trends and strong demand across key sectors.
Recent Developments in the Drug Delivery CDMO Market
- In February 2026, Avery Pharmaceuticals Pvt. Ltd. announced its participation in the Vitafoods India 2026, where it will exhibit its cutting-edge solutions in drug delivery, contract manufacturing development services for orally dissolving strips, and engage the technical and commercial team with the attendees.
- In January 2026, with an aim to expand the suite of integrated solutions, the AI-powered software for high-throughput salt and co-crystal screening will be developed and launched by Eurofins CDMO Alphora.
Your Drug Delivery CDMO Market insights, organized in one powerful dashboard: Access Now
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking
